Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_assertion type Assertion NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_head.
- NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_provenance.
- NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_assertion evidence source_evidence_literature NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_provenance.
- NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_assertion SIO_000772 20652941 NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_provenance.
- NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_assertion wasDerivedFrom gad-20150221 NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_provenance.
- NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_assertion wasGeneratedBy ECO_0000203 NP76770.RAOA7PkIxunxuRC9IICuFeMxIhoFB-_DpRzE8BDNhtc-Q130_provenance.